Table 1The Number of Korean Population according to Age in 2010
|
All |
Men |
Women |
Age, yr |
|
|
|
≤4 |
2,219,084 |
1,142,220 |
1,076,864 |
5-9 |
2,394,663 |
1,243,294 |
1,151,369 |
10-14 |
3,173,226 |
1,654,964 |
1,518,262 |
15-19 |
3,438,414 |
1,826,179 |
1,612,235 |
20-24 |
3,055,420 |
1,625,371 |
1,430,049 |
25-29 |
3,538,949 |
1,802,805 |
1,736,144 |
30-34 |
3,695,348 |
1,866,397 |
1,828,951 |
35-39 |
4,099,147 |
2,060,233 |
2,038,914 |
40-44 |
4,131,423 |
2,071,431 |
2,059,992 |
45-49 |
4,073,358 |
2,044,641 |
2,028,717 |
50-54 |
3,798,131 |
1,887,973 |
1,910,158 |
55-59 |
2,766,695 |
1,360,747 |
1,405,948 |
60-64 |
2,182,236 |
1,057,035 |
1,125,201 |
65-69 |
1,812,168 |
833,242 |
978,926 |
70-74 |
1,566,014 |
672,894 |
893,120 |
75-79 |
1,084,367 |
410,726 |
673,641 |
80-84 |
595,509 |
186,008 |
409,501 |
≥85 |
366,609 |
94,736 |
271,873 |
Total |
47,990,761 |
23,840,896 |
24,149,865 |
Table 2Annual Mean Incidence of Patients with Hypothyroidism Taking Levothyroxine from 2008 to 2012
|
Men |
Women |
All |
Incidencea
|
Number |
Incidencea
|
Number |
Incidencea
|
Number |
Age, yr |
|
|
|
|
|
|
≤4 |
0.30 |
1,718 |
0.27 |
1,459 |
0.29 |
3,177 |
5-9 |
0.06 |
362 |
0.19 |
1,102 |
0.12 |
1,464 |
10-14 |
0.07 |
579 |
0.32 |
2,466 |
0.19 |
3,045 |
15-19 |
0.09 |
807 |
0.48 |
3,843 |
0.27 |
4,650 |
20-24 |
0.14 |
1,115 |
1.10 |
7,881 |
0.59 |
8,996 |
25-29 |
0.30 |
2,718 |
2.81 |
24,330 |
1.53 |
27,048 |
30-34 |
0.54 |
5,016 |
4.43 |
40,499 |
2.46 |
45,515 |
35-39 |
0.78 |
7,993 |
4.39 |
44,770 |
2.57 |
52,763 |
40-44 |
0.92 |
9,518 |
4.81 |
49,514 |
2.86 |
59,032 |
45-49 |
1.08 |
11,034 |
6.14 |
62,297 |
3.60 |
73,331 |
50-54 |
1.34 |
12,650 |
7.19 |
68,676 |
4.28 |
81,326 |
55-59 |
1.54 |
10,476 |
6.96 |
48,894 |
4.29 |
59,370 |
60-64 |
1.72 |
9,091 |
6.26 |
35,203 |
4.06 |
44,294 |
65-69 |
1.91 |
7,971 |
5.44 |
26,641 |
3.82 |
34,612 |
70-74 |
1.65 |
5,546 |
3.77 |
16,818 |
2.86 |
22,364 |
75-79 |
1.58 |
3,251 |
2.59 |
8,735 |
2.21 |
11,986 |
80-84 |
1.56 |
1,448 |
1.79 |
3,675 |
1.72 |
5,123 |
≥85 |
3.25 |
1,539 |
1.72 |
2,334 |
2.11 |
3,873 |
Total |
0.78 |
92,832 |
3.72 |
449,137 |
2.26 |
541,969 |
Table 3Prevalence of Patients with Hypothyroidism Taking Levothyroxine in 2012
|
Men |
Women |
All |
Prevalencea
|
Number |
Prevalencea
|
Number |
Prevalencea
|
Number |
Age, yr |
|
|
|
|
|
|
≤4 |
1.42 |
1,618 |
1.37 |
1,470 |
1.39 |
3,088 |
5-9 |
0.65 |
805 |
0.87 |
998 |
0.75 |
1,803 |
10-14 |
0.50 |
832 |
1.40 |
2,121 |
0.93 |
2,953 |
15-19 |
0.47 |
853 |
1.92 |
3,098 |
1.15 |
3,951 |
20-24 |
0.66 |
1,071 |
3.73 |
5,334 |
2.10 |
6,405 |
25-29 |
1.12 |
2,027 |
8.48 |
14,715 |
4.73 |
16,742 |
30-34 |
2.34 |
4,371 |
19.56 |
35,769 |
10.86 |
40,140 |
35-39 |
3.46 |
7,136 |
22.95 |
46,786 |
13.15 |
53,922 |
40-44 |
4.90 |
10,140 |
28.82 |
59,362 |
16.82 |
69,502 |
45-49 |
5.50 |
11,248 |
33.48 |
67,930 |
19.44 |
79,178 |
50-54 |
7.65 |
14,442 |
47.85 |
91,406 |
27.87 |
105,848 |
55-59 |
9.69 |
13,180 |
55.85 |
78,521 |
33.14 |
91,701 |
60-64 |
10.33 |
10,921 |
52.85 |
59,469 |
32.26 |
70,390 |
65-69 |
11.83 |
9,854 |
46.63 |
45,650 |
30.63 |
55,504 |
70-74 |
12.15 |
8,178 |
39.51 |
35,291 |
27.76 |
43,469 |
75-79 |
11.71 |
4,810 |
29.76 |
20,050 |
22.93 |
24,860 |
80-84 |
11.77 |
2,190 |
21.54 |
8,821 |
18.49 |
11,011 |
≥85 |
11.85 |
1,123 |
12.91 |
3,511 |
12.64 |
4,634 |
Total |
4.40 |
104,799 |
24.03 |
580,302 |
14.28 |
685,101 |
Table 4Annual Mean Incidence of Patients with Thyroid Cancer Taking Levothyroxine from 2008 to 2012
|
Men |
Women |
All |
Incidence |
Number |
Incidence |
Number |
Incidence |
Number |
Age, yr |
|
|
|
|
|
|
≤4 |
0 |
0 |
0 |
1 |
0 |
1 |
5-9 |
0 |
7 |
0 |
14 |
0 |
21 |
10-14 |
0 |
26 |
0.01 |
101 |
0.01 |
127 |
15-19 |
0.01 |
112 |
0.07 |
525 |
0.04 |
637 |
20-24 |
0.04 |
336 |
0.25 |
1,773 |
0.14 |
2,109 |
25-29 |
0.12 |
1,099 |
0.64 |
5,524 |
0.37 |
6,623 |
30-34 |
0.24 |
2,283 |
1.14 |
10,442 |
0.69 |
12,725 |
35-39 |
0.36 |
3,707 |
1.54 |
15,677 |
0.95 |
19,384 |
40-44 |
0.4 |
4,194 |
1.89 |
19,489 |
1.15 |
23,683 |
45-49 |
0.42 |
4,295 |
2.26 |
22,931 |
1.34 |
27,226 |
50-54 |
0.45 |
4,275 |
2.47 |
23,611 |
1.47 |
27,886 |
55-59 |
0.43 |
2,914 |
2.26 |
15,872 |
1.36 |
18,786 |
60-64 |
0.39 |
2,060 |
1.89 |
10,641 |
1.16 |
12,701 |
65-69 |
0.37 |
1,528 |
1.44 |
7,057 |
0.95 |
8,585 |
70-74 |
0.23 |
781 |
0.86 |
3,829 |
0.59 |
4,610 |
75-79 |
0.15 |
315 |
0.42 |
1,399 |
0.32 |
1,714 |
80-84 |
0.08 |
77 |
0.17 |
345 |
0.14 |
422 |
≥85 |
0.05 |
22 |
0.05 |
73 |
0.05 |
95 |
Total |
0.24 |
28,031 |
1.15 |
139,304 |
0.7 |
167,335 |
Table 5Annual Mean Incidence of Patients with Hyperthyroidism Taking Levothyroxine after Thyroidectomy or Radioiodine Ablation from 2008 to 2012
|
Men |
Women |
All |
Incidence |
Number |
Incidence |
Number |
Incidence |
Number |
Age, yr |
|
|
|
|
|
|
≤4 |
0 |
0 |
0 |
0 |
0 |
0 |
5-9 |
0 |
0 |
0 |
0 |
0 |
0 |
10-14 |
0 |
1 |
0 |
7 |
0 |
8 |
15-19 |
0 |
26 |
0.01 |
107 |
0.01 |
133 |
20-24 |
0.01 |
62 |
0.03 |
211 |
0.02 |
273 |
25-29 |
0.01 |
132 |
0.04 |
351 |
0.03 |
483 |
30-34 |
0.02 |
165 |
0.04 |
355 |
0.03 |
520 |
35-39 |
0.02 |
231 |
0.04 |
432 |
0.03 |
663 |
40-44 |
0.02 |
213 |
0.04 |
438 |
0.03 |
651 |
45-49 |
0.02 |
202 |
0.04 |
421 |
0.03 |
623 |
50-54 |
0.02 |
165 |
0.04 |
383 |
0.03 |
548 |
55-59 |
0.02 |
109 |
0.04 |
254 |
0.03 |
363 |
60-64 |
0.01 |
71 |
0.03 |
180 |
0.02 |
251 |
65-69 |
0.01 |
48 |
0.03 |
133 |
0.02 |
181 |
70-74 |
0 |
14 |
0.01 |
57 |
0.01 |
71 |
75-79 |
0 |
3 |
0.01 |
31 |
0.01 |
34 |
80-84 |
0 |
0 |
0 |
8 |
0 |
8 |
≥85 |
0 |
1 |
0 |
0 |
0 |
1 |
Total |
0.01 |
1,443 |
0.03 |
3,368 |
0.02 |
4,811 |
Table 6Annual Mean Incidence of Patients with Other Thyroid Disease Taking Levothyroxine after Thyroidectomy or Radioiodine Ablation from 2008 to 2012
|
Men |
Women |
All |
Incidence |
Number |
Incidence |
Number |
Incidence |
Number |
Age, yr |
|
|
|
|
|
|
≤4 |
0 |
0 |
0 |
0 |
0 |
0 |
5-9 |
0 |
0 |
0 |
3 |
0 |
3 |
10-14 |
0 |
3 |
0 |
12 |
0 |
15 |
15-19 |
0 |
18 |
0.01 |
74 |
0.01 |
92 |
20-24 |
0 |
18 |
0.02 |
130 |
0.01 |
148 |
25-29 |
0 |
28 |
0.03 |
276 |
0.02 |
304 |
30-34 |
0.01 |
74 |
0.05 |
489 |
0.03 |
563 |
35-39 |
0.01 |
127 |
0.08 |
846 |
0.05 |
973 |
40-44 |
0.02 |
179 |
0.10 |
1,076 |
0.06 |
1,255 |
45-49 |
0.02 |
233 |
0.17 |
1,674 |
0.09 |
1,907 |
50-54 |
0.04 |
348 |
0.20 |
1,888 |
0.12 |
2,236 |
55-59 |
0.05 |
324 |
0.21 |
1,472 |
0.13 |
1,796 |
60-64 |
0.05 |
273 |
0.21 |
1,175 |
0.13 |
1,448 |
65-69 |
0.05 |
223 |
0.19 |
906 |
0.12 |
1,129 |
70-74 |
0.03 |
115 |
0.11 |
495 |
0.08 |
610 |
75-79 |
0.03 |
52 |
0.05 |
182 |
0.04 |
234 |
80-84 |
0.02 |
15 |
0.02 |
38 |
0.02 |
53 |
≥85 |
0 |
1 |
0.01 |
8 |
0 |
9 |
Total |
0.02 |
2,031 |
0.09 |
10,744 |
0.05 |
12,775 |
Table 7Annual Mean Incidence of Patients with Hashimoto's Thyroiditis Taking Levothyroxine from 2008 to 2012
|
Men |
Women |
All |
Incidence |
Number |
Incidence |
Number |
Incidence |
Number |
Age, yr |
|
|
|
|
|
|
≤4 |
0 |
6 |
0 |
9 |
0 |
15 |
5-9 |
0.01 |
34 |
0.05 |
286 |
0.03 |
320 |
10-14 |
0.01 |
55 |
0.09 |
650 |
0.04 |
705 |
15-19 |
0 |
43 |
0.06 |
492 |
0.03 |
535 |
20-24 |
0 |
38 |
0.13 |
924 |
0.06 |
962 |
25-29 |
0.01 |
96 |
0.33 |
2,891 |
0.17 |
2,987 |
30-34 |
0.02 |
209 |
0.50 |
4,601 |
0.26 |
4,810 |
35-39 |
0.03 |
327 |
0.38 |
3,853 |
0.20 |
4,180 |
40-44 |
0.04 |
376 |
0.35 |
3,578 |
0.19 |
3,954 |
45-49 |
0.05 |
466 |
0.43 |
4,406 |
0.24 |
4,872 |
50-54 |
0.05 |
510 |
0.51 |
4,868 |
0.28 |
5,378 |
55-59 |
0.07 |
463 |
0.47 |
3,298 |
0.27 |
3,761 |
60-64 |
0.07 |
395 |
0.36 |
2,016 |
0.22 |
2,411 |
65-69 |
0.07 |
307 |
0.26 |
1,278 |
0.17 |
1,585 |
70-74 |
0.05 |
177 |
0.14 |
628 |
0.10 |
805 |
75-79 |
0.04 |
91 |
0.09 |
307 |
0.07 |
398 |
80-84 |
0.05 |
44 |
0.04 |
86 |
0.04 |
130 |
≥85 |
0.03 |
12 |
0.02 |
21 |
0.02 |
33 |
Total |
0.03 |
3,649 |
0.28 |
34,192 |
0.16 |
37,841 |
Table 8Annual Mean Incidence of Patients with Other Thyroiditis Taking Levothyroxine from 2008 to 2012
|
Men |
Women |
All |
Incidence |
Number |
Incidence |
Number |
Incidence |
Number |
Age, yr |
|
|
|
|
|
|
≤4 |
0 |
14 |
0 |
12 |
0 |
26 |
5-9 |
0 |
9 |
0.01 |
65 |
0.01 |
74 |
10-14 |
0 |
24 |
0.03 |
192 |
0.01 |
216 |
15-19 |
0.01 |
48 |
0.03 |
277 |
0.02 |
325 |
20-24 |
0 |
38 |
0.07 |
513 |
0.04 |
551 |
25-29 |
0.01 |
68 |
0.21 |
1,825 |
0.11 |
1,893 |
30-34 |
0.01 |
131 |
0.30 |
2,780 |
0.16 |
2,911 |
35-39 |
0.02 |
208 |
0.23 |
2,385 |
0.13 |
2,593 |
40-44 |
0.03 |
275 |
0.22 |
2,231 |
0.12 |
2,506 |
45-49 |
0.03 |
276 |
0.27 |
2,703 |
0.15 |
2,979 |
50-54 |
0.03 |
321 |
0.29 |
2,817 |
0.17 |
3,138 |
55-59 |
0.04 |
258 |
0.24 |
1,702 |
0.14 |
1,960 |
60-64 |
0.04 |
221 |
0.18 |
1,011 |
0.11 |
1,232 |
65-69 |
0.04 |
180 |
0.15 |
720 |
0.10 |
900 |
70-74 |
0.03 |
113 |
0.09 |
404 |
0.07 |
517 |
75-79 |
0.03 |
66 |
0.05 |
178 |
0.05 |
244 |
80-84 |
0.03 |
25 |
0.02 |
51 |
0.03 |
76 |
≥85 |
0.02 |
9 |
0.02 |
25 |
0.02 |
34 |
Total |
0.02 |
2,284 |
0.16 |
19,891 |
0.09 |
22,175 |
Table 9Annual Mean Incidence of Patients with Benign Thyroid Tumor or Goiter Taking Levothyroxine from 2008 to 2012
|
Men |
Women |
All |
Incidence |
Number |
Incidence |
Number |
Incidence |
Number |
Age, yr |
|
|
|
|
|
|
≤4 |
0 |
7 |
0 |
12 |
0 |
19 |
5-9 |
0 |
20 |
0.02 |
142 |
0.01 |
162 |
10-14 |
0.01 |
66 |
0.05 |
417 |
0.03 |
483 |
15-19 |
0.01 |
62 |
0.08 |
678 |
0.04 |
740 |
20-24 |
0.01 |
85 |
0.17 |
1,236 |
0.09 |
1,321 |
25-29 |
0.02 |
215 |
0.37 |
3,216 |
0.19 |
3,431 |
30-34 |
0.04 |
377 |
0.58 |
5,294 |
0.31 |
5,671 |
35-39 |
0.07 |
670 |
0.66 |
6,706 |
0.36 |
7,376 |
40-44 |
0.08 |
878 |
0.81 |
8,384 |
0.45 |
9,262 |
45-49 |
0.12 |
1,236 |
1.18 |
11,961 |
0.65 |
13,197 |
50-54 |
0.17 |
1,600 |
1.48 |
14,148 |
0.83 |
15,748 |
55-59 |
0.22 |
1,483 |
1.51 |
10,649 |
0.88 |
12,132 |
60-64 |
0.23 |
1,234 |
1.35 |
7,615 |
0.81 |
8,849 |
65-69 |
0.25 |
1,052 |
1.13 |
5,552 |
0.73 |
6,604 |
70-74 |
0.19 |
635 |
0.66 |
2,946 |
0.46 |
3,581 |
75-79 |
0.12 |
249 |
0.38 |
1,266 |
0.28 |
1,515 |
80-84 |
0.08 |
70 |
0.19 |
396 |
0.16 |
466 |
≥85 |
0.06 |
27 |
0.08 |
104 |
0.07 |
131 |
Total |
0.08 |
9,966 |
0.67 |
80,722 |
0.38 |
90,688 |
Table 10Annual Mean Incidence of Patients with Other Hypothyroidism Taking Levothyroxine from 2008 to 2012
|
Men |
Women |
All |
Incidence |
Number |
Incidence |
Number |
Incidence |
Number |
Age, yr |
|
|
|
|
|
|
≤4 |
0.30 |
1,691 |
0.26 |
1,425 |
0.28 |
3,116 |
5-9 |
0.05 |
292 |
0.10 |
592 |
0.07 |
884 |
10-14 |
0.05 |
404 |
0.14 |
1,087 |
0.09 |
1,491 |
15-19 |
0.05 |
498 |
0.21 |
1,690 |
0.13 |
2,188 |
20-24 |
0.07 |
538 |
0.43 |
3,094 |
0.24 |
3,632 |
25-29 |
0.12 |
1,080 |
1.18 |
10,247 |
0.64 |
11,327 |
30-34 |
0.19 |
1,777 |
1.81 |
16,538 |
0.99 |
18,315 |
35-39 |
0.26 |
2,723 |
1.46 |
14,871 |
0.86 |
17,594 |
40-44 |
0.33 |
3,403 |
1.39 |
14,318 |
0.86 |
17,721 |
45-49 |
0.42 |
4,326 |
1.79 |
18,201 |
1.11 |
22,527 |
50-54 |
0.58 |
5,431 |
2.19 |
20,961 |
1.39 |
26,392 |
55-59 |
0.72 |
4,925 |
2.23 |
15,647 |
1.49 |
20,572 |
60-64 |
0.92 |
4,837 |
2.23 |
12,565 |
1.59 |
17,402 |
65-69 |
1.11 |
4,633 |
2.25 |
10,995 |
1.72 |
15,628 |
70-74 |
1.10 |
3,711 |
1.89 |
8,459 |
1.55 |
12,170 |
75-79 |
1.21 |
2,475 |
1.59 |
5,372 |
1.45 |
7,847 |
80-84 |
1.31 |
1,217 |
1.34 |
2,751 |
1.33 |
3,968 |
≥85 |
3.10 |
1,467 |
1.55 |
2,103 |
1.95 |
3,570 |
Total |
0.38 |
45,428 |
1.33 |
160,916 |
0.86 |
206,344 |